Synergy CHC Corp. (Uplisting) (SNYR) Competitors $2.29 +0.19 (+9.05%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock SNYR vs. BYSI, CRVO, RENB, VTGN, ANRO, MNOV, SRZN, ZIVO, IMUX, and IMRXShould you be buying Synergy CHC Corp. (Uplisting) stock or one of its competitors? The main competitors of Synergy CHC Corp. (Uplisting) include BeyondSpring (BYSI), CervoMed (CRVO), Renovaro (RENB), Vistagen Therapeutics (VTGN), Alto Neuroscience (ANRO), MediciNova (MNOV), Surrozen (SRZN), ZIVO Bioscience (ZIVO), Immunic (IMUX), and Immuneering (IMRX). These companies are all part of the "pharmaceutical products" industry. Synergy CHC Corp. (Uplisting) vs. Its Competitors BeyondSpring CervoMed Renovaro Vistagen Therapeutics Alto Neuroscience MediciNova Surrozen ZIVO Bioscience Immunic Immuneering Synergy CHC Corp. (Uplisting) (NASDAQ:SNYR) and BeyondSpring (NASDAQ:BYSI) are both small-cap consumer staples companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, community ranking, analyst recommendations, profitability, earnings and media sentiment. Which has better valuation & earnings, SNYR or BYSI? Synergy CHC Corp. (Uplisting) has higher revenue and earnings than BeyondSpring. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSynergy CHC Corp. (Uplisting)$33.59M0.63N/AN/AN/ABeyondSpring$1.88M60.82-$21.03MN/AN/A Does the media prefer SNYR or BYSI? In the previous week, Synergy CHC Corp. (Uplisting) had 7 more articles in the media than BeyondSpring. MarketBeat recorded 9 mentions for Synergy CHC Corp. (Uplisting) and 2 mentions for BeyondSpring. BeyondSpring's average media sentiment score of 1.09 beat Synergy CHC Corp. (Uplisting)'s score of 0.94 indicating that BeyondSpring is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Synergy CHC Corp. (Uplisting) 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BeyondSpring 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor SNYR or BYSI? BeyondSpring received 183 more outperform votes than Synergy CHC Corp. (Uplisting) when rated by MarketBeat users. Likewise, 66.79% of users gave BeyondSpring an outperform vote while only 66.67% of users gave Synergy CHC Corp. (Uplisting) an outperform vote. CompanyUnderperformOutperformSynergy CHC Corp. (Uplisting)Outperform Votes266.67% Underperform Votes133.33% BeyondSpringOutperform Votes18566.79% Underperform Votes9233.21% Is SNYR or BYSI more profitable? Company Net Margins Return on Equity Return on Assets Synergy CHC Corp. (Uplisting)N/A N/A N/A BeyondSpring N/A N/A N/A Do analysts rate SNYR or BYSI? Synergy CHC Corp. (Uplisting) presently has a consensus target price of $10.00, suggesting a potential upside of 336.68%. Given Synergy CHC Corp. (Uplisting)'s stronger consensus rating and higher possible upside, analysts plainly believe Synergy CHC Corp. (Uplisting) is more favorable than BeyondSpring.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synergy CHC Corp. (Uplisting) 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50BeyondSpring 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders & institutionals believe in SNYR or BYSI? 40.3% of BeyondSpring shares are held by institutional investors. 56.6% of Synergy CHC Corp. (Uplisting) shares are held by company insiders. Comparatively, 29.3% of BeyondSpring shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummarySynergy CHC Corp. (Uplisting) beats BeyondSpring on 7 of the 12 factors compared between the two stocks. Get Synergy CHC Corp. (Uplisting) News Delivered to You Automatically Sign up to receive the latest news and ratings for SNYR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SNYR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNYR vs. The Competition Export to ExcelMetricSynergy CHC Corp. (Uplisting)Medicinals & botanicals IndustryStaples SectorNASDAQ ExchangeMarket Cap$21.05M$1.20B$17.57B$8.62BDividend YieldN/AN/A3.06%4.17%P/E RatioN/A12.4816.4219.96Price / Sales0.6311.1643.36157.63Price / CashN/A10.4016.3934.64Price / BookN/A1.496.194.69Net IncomeN/A-$56.07M$734.57M$248.14M7 Day Performance22.46%2.01%1.30%2.39%1 Month Performance25.14%0.70%0.55%6.05%1 Year PerformanceN/A-31.51%2.74%13.60% Synergy CHC Corp. (Uplisting) Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNYRSynergy CHC Corp. (Uplisting)3.825 of 5 stars$2.29+9.0%$10.00+336.7%N/A$21.05M$33.59M0.0040News CoverageBYSIBeyondSpringN/A$1.74-0.6%N/A+23.3%$69.95M$1.88M0.0080Positive NewsCRVOCervoMed3.2183 of 5 stars$7.99+10.7%$27.63+245.7%-62.3%$69.89M$7.14M-3.684News CoveragePositive NewsAnalyst ForecastShort Interest ↓RENBRenovaro1.7666 of 5 stars$0.41+39.7%N/A-76.4%$69.71MN/A-0.4420High Trading VolumeVTGNVistagen Therapeutics1.4188 of 5 stars$2.42-0.6%N/A-37.4%$69.70M$698K-1.6340News CoveragePositive NewsGap DownANROAlto Neuroscience1.6891 of 5 stars$2.57-1.2%$15.40+499.2%-79.4%$69.58MN/A-1.10N/AHigh Trading VolumeMNOVMediciNova2.1457 of 5 stars$1.42+0.4%$9.00+536.0%+2.3%$69.40M$1M-6.1510Positive NewsSRZNSurrozen3.8001 of 5 stars$7.95-6.4%$38.50+384.3%-20.9%$68.29M$11.64M-0.3280Positive NewsZIVOZIVO Bioscience0.4689 of 5 stars$17.51-6.5%N/A+75.5%$66.77M$15.85K-3.5910Positive NewsGap DownIMUXImmunic3.2264 of 5 stars$0.69-0.9%$11.60+1,571.5%-31.5%$66.59MN/A-0.5770Short Interest ↑IMRXImmuneering2.9757 of 5 stars$1.84-1.6%$15.33+733.3%+25.4%$66.21M$320K-0.9360News CoveragePositive NewsShort Interest ↑ Related Companies and Tools Related Companies BeyondSpring Competitors CervoMed Competitors Renovaro Competitors Vistagen Therapeutics Competitors Alto Neuroscience Competitors MediciNova Competitors Surrozen Competitors ZIVO Bioscience Competitors Immunic Competitors Immuneering Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNYR) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synergy CHC Corp. (Uplisting) Please log in to your account or sign up in order to add this asset to your watchlist. Share Synergy CHC Corp. (Uplisting) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SNYR Stock Free SNYR Stock Alerts